Pharmexcil urges a review of a new rule for drug exports in India, which requires a product registration certificate from the ...

The move came following reports that unapproved combinations of these drugs, exported to West African countries, are contributing to an opioid crisis in the region.

The Drugs Controller General of India (DCGI) has prohibited the production and export of all combinations of pain-relief medicines tapentadol and carisoprodol over news reports that unapproved ...